Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manal M Anwar

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Bioorganic Chemistry|June 27, 2022
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitorsZahra M Alamshany, Nada Y Tashkandi, Ismail M M Othman, et al.
Acta Poloniae Pharmaceutica|August 4, 2009
Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivativesKamelia M Amin, Magdi I El-Zahar, Manal M Anwar, et al.
Future Medicinal Chemistry|December 14, 2017
Synthesis and molecular modeling of new benzimidazoles as glutathione S-transferase inhibitors and anticancer agentsSomaia S Abd El-Karim, Manal M Anwar, Eman R Zaki, et al.
ACS Omega|March 7, 2022
New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFR<sup>WT</sup> and EGFR<sup>T790M</sup> Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking StudyHeba E Hashem, Abd El-Galil E Amr, Eman S Nossier, et al.
Molecules (Basel, Switzerland)|August 12, 2022
New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational StudiesYasmin M Syam, Manal M Anwar, Somaia S Abd El-Karim, et al.
Molecules (Basel, Switzerland)|October 16, 2024
Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine-Benzenesulfonamide CompoundsAbdalrahman Khalifa, Manal M Anwar, Walaa A Alshareef, et al.
Future Medicinal Chemistry|December 9, 2024
New thiazolidin-4-ones as anti-cervical cancer agents targeting EGFR: design, synthesis, and computational studiesWafa A Bawazir, Nesreen S Ahmed, Somaia S Abd El-Karim, et al.
Molecules (Basel, Switzerland)|February 24, 2024
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present)Heba T Abdel-Mohsen, Manal M Anwar, Nesreen S Ahmed, et al.
RSC Advances|October 3, 2025
Design, synthesis, and <i>in silico</i> studies of new benzofuran-pyrazole hybrids as multi-kinase inhibitors with potential antiproliferative activitySomaia S Abd El-Karim, Yasmin M Syam, Reham M Abdelkader, et al.
Bioorganic & Medicinal Chemistry|August 24, 2020
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitorsAladdin M Srour, Nesreen S Ahmed, Somaia S Abd El-Karim, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic Chemistry|June 27, 2022
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitorsZahra M Alamshany, Nada Y Tashkandi, Ismail M M Othman, et al.
Acta Poloniae Pharmaceutica|August 4, 2009
Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivativesKamelia M Amin, Magdi I El-Zahar, Manal M Anwar, et al.
Future Medicinal Chemistry|December 14, 2017
Synthesis and molecular modeling of new benzimidazoles as glutathione S-transferase inhibitors and anticancer agentsSomaia S Abd El-Karim, Manal M Anwar, Eman R Zaki, et al.
ACS Omega|March 7, 2022
New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFR<sup>WT</sup> and EGFR<sup>T790M</sup> Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking StudyHeba E Hashem, Abd El-Galil E Amr, Eman S Nossier, et al.
Molecules (Basel, Switzerland)|August 12, 2022
New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational StudiesYasmin M Syam, Manal M Anwar, Somaia S Abd El-Karim, et al.
Molecules (Basel, Switzerland)|October 16, 2024
Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine-Benzenesulfonamide CompoundsAbdalrahman Khalifa, Manal M Anwar, Walaa A Alshareef, et al.
Future Medicinal Chemistry|December 9, 2024
New thiazolidin-4-ones as anti-cervical cancer agents targeting EGFR: design, synthesis, and computational studiesWafa A Bawazir, Nesreen S Ahmed, Somaia S Abd El-Karim, et al.
Molecules (Basel, Switzerland)|February 24, 2024
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present)Heba T Abdel-Mohsen, Manal M Anwar, Nesreen S Ahmed, et al.
RSC Advances|October 3, 2025
Design, synthesis, and <i>in silico</i> studies of new benzofuran-pyrazole hybrids as multi-kinase inhibitors with potential antiproliferative activitySomaia S Abd El-Karim, Yasmin M Syam, Reham M Abdelkader, et al.
Bioorganic & Medicinal Chemistry|August 24, 2020
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitorsAladdin M Srour, Nesreen S Ahmed, Somaia S Abd El-Karim, et al.
Pageof 6